Photo of Ann-Charlotte Johansson

Ann-Charlotte Johansson

Head of Unit, Senior Research Coordinator




Emilia Wiechec, Mustafa Magan Barre, Natasa Matic, Anna Ansell - Schultz, Matti Kankainen, Outi Monni, Ann-Charlotte Johansson, Karin Roberg (2021) Cancer-Associated Fibroblasts Modulate Transcriptional Signatures Involved in Proliferation, Differentiation and Metastasis in Head and Neck Squamous Cell Carcinoma Cancers, Vol. 13, Article 3361 Continue to DOI


Johannes Ydrefors, Tomas Karlsson, Ulrika Wentzel Olausson, Bijar Ghafouri, Ann-Charlotte Johansson, Håkan Olausson, Björn Gerdle, Saad Nagi (2020) Automated Nociceptive Withdrawal Reflex Measurements Reveal Normal Reflex Thresholds and Augmented Pain Ratings in Patients with Fibromyalgia Journal of Clinical Medicine, Vol. 9, Article 1992 Continue to DOI


Adam Jedlinski, Stina Garvin, Ann-Charlotte Johansson, Per-Henrik Edqvist, Fredrik Pontén, Karin Roberg (2017) Cetuximab sensitivity of head and neck squamous cell carcinoma xenografts is associated with treatment-induced reduction of EGFR, pEGFR, and pSrc Journal of Oral Pathology & Medicine, Vol. 9, p. 717-724 Continue to DOI


Anna Ansell, Adam Jedlinski, Ann-Charlotte Johansson, Karin Roberg (2016) Epidermal growth factor is a biomarker for poor cetuximab response in tongue cancer cells Journal of Oral Pathology & Medicine, Vol. 45, p. 9-16 Continue to DOI
Ann-Charlotte Johansson, Linnea La Fleur, Styliani Melissaridou, Karin Roberg (2016) The relationship between EMT, CD44(high)/EGFR(low) phenotype, and treatment response in head and neck cancer cell lines Journal of Oral Pathology & Medicine, Vol. 45, p. 640-646 Continue to DOI